This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Carnegie Mellon University. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Innovations of Liang Tso Sun in Inflammation Regulation
Introduction
Liang Tso Sun is an accomplished inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of inflammation regulation through his innovative patent. His work focuses on developing compositions and methods that provide local control over inflammation, which is crucial for various medical applications.
Latest Patents
Liang Tso Sun holds a patent titled "Inflammation-regulating compositions and methods." This patent describes a composition that localizes the activities of cytokine-neutralizing antibodies to the site of inflammation through covalent attachment to hydrophilic matrices. The composition includes a hydrophilic polymer, a ligand binding moiety, and optionally, a cellular adhesion peptide. The hydrophilic polymer may be a glycosaminoglycan such as hyaluronan. The cellular adhesion peptide may be a linear RGD peptide sequence, while the ligand binding moiety may be a monoclonal antibody. This innovative approach functions to inhibit the inflammatory response and promote tissue regeneration.
Career Highlights
Liang Tso Sun is affiliated with Carnegie Mellon University, where he continues to advance his research in inflammation regulation. His work has the potential to impact various medical fields, particularly in developing targeted therapies for inflammatory diseases.
Collaborations
Liang Tso Sun has collaborated with notable colleagues, including Newell Raymond Washburn and Sidi A Bencherif. These collaborations have contributed to the advancement of his research and the development of innovative solutions in the field.
Conclusion
Liang Tso Sun's contributions to inflammation regulation through his patent demonstrate his commitment to advancing medical science. His innovative approaches have the potential to significantly improve treatment options for patients suffering from inflammatory conditions.